AVTX
Avalo Therapeutics Inc
15.70$
+2.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +2,312.2% | -34.1% | -63.2% | -0.8% | -19.4% | +234.4% | -89.3% | -77.1% | -86.6% | |
| – | -99.8% | +34,947.6% | -92.3% | +1,076.5% | -107.6% | – | +397.0% | +130.3% | -62.6% | -128.5% | – | |
| – | – | – | – | -60.1% | -32.6% | -12.5% | -38.9% | +274.1% | -95.6% | +26.1% | -92.7% | |
| – | -46.2% | +54.1% | -56.9% | +32.3% | +103.3% | +173.7% | +85.9% | -47.7% | -56.0% | +277.8% | -3.8% | |
| – | -9.3% | +60.1% | +12.1% | +34.4% | -5.2% | +72.1% | +32.1% | -10.3% | -50.2% | +60.2% | +36.3% | |
| – | -35.7% | +56.5% | -22.9% | +122.2% | -20.5% | -72.7% | +1,244.6% | -39.5% | -46.2% | +147.6% | +5.3% | |
| – | – | – | – | -383.0% | – | – | – | – | – | – | – | |
| – | -34.2% | -41.5% | -94.8% | +3,279.5% | +258.2% | +1,253.3% | -93.9% | +74.4% | -18.1% | -2.9% | – | |
| – | – | – | – | -389.7% | – | – | – | – | – | – | – | |
| – | – | – | +440.0% | -101.7% | – | -1,096.4% | – | – | -50.0% | +714.3% | +44.7% | |
| – | – | – | – | -437.4% | – | – | – | – | – | – | – | |
| – | – | – | – | -191.1% | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.